Patents by Inventor Konstantinos Mavrommatis

Konstantinos Mavrommatis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SIRP-Alpha BINDING PROTEINS AND METHODS OF USE THEREOF
    Publication number: 20240034789
    Abstract: Provided herein are compositions, methods and uses involving antibodies that specifically bind to signal regulatory protein-? (SIRP?) and modulate the activity of SIRP?.
    Type: Application
    Filed: February 1, 2023
    Publication date: February 1, 2024
    Inventors: Mahan Abbasian, Henry H. Chan, Laure Escoubet, Gustavo Fenalti, Kandasamy Hariharan, Monica Wai Ling Leung, Konstantinos Mavrommatis, David P. Mikolon, Heather K. Raymon, Carlo Steven Santos, Jeonghoon Sun, Christina Valerie Trout
  • SIRP-? binding proteins and methods of use thereof
    Patent number: 11591390
    Abstract: Provided herein are compositions, methods and uses involving antibodies that specifically bind to signal regulatory protein-? (SIRP?) and modulate the activity of SIRP?.
    Type: Grant
    Filed: September 25, 2019
    Date of Patent: February 28, 2023
    Assignee: Celgene Corporation
    Inventors: Mahan Abbasian, Henry H. Chan, Laure Escoubet, Gustavo Fenalti, Kandasamy Hariharan, Monica Wai Ling Leung, Konstantinos Mavrommatis, David P. Mikolon, Heather K. Raymon, Carlo Steven Santos, Jeonghoon Sun, Christina Valerie Trout
  • SIRP-Alpha BINDING PROTEINS AND METHODS OF USE THEREOF
    Publication number: 20200102387
    Abstract: Provided herein are compositions, methods and uses involving antibodies that specifically bind to signal regulatory protein-? (SIRP?) and modulate the activity of SIRP?.
    Type: Application
    Filed: September 25, 2019
    Publication date: April 2, 2020
    Inventors: Mahan Abbasian, Henry H. Chan, Laure Escoubet, Gustavo Fenalti, Kandasamy Hariharan, Monica Wai Ling Leung, Konstantinos Mavrommatis, David P. Mikolon, Heather K. Raymon, Carlo Steven Santos, Jeonghoon Sun, Christina Valerie Trout
  • TREATMENT OF CANCER CHARACTERIZED BY GENE MUTATIONS
    Publication number: 20150099754
    Abstract: Provided herein are methods for treating and/or preventing a cancer in a patient, comprising administering an effective amount of a TOR kinase inhibitor to a patient having cancer characterized by particular gene mutation(s) or variant(s) relative to the genes of a biological wild-type sample.
    Type: Application
    Filed: October 3, 2014
    Publication date: April 9, 2015
    Inventors: Shuichan Xu, Kristen Mae Hege, Xiaoling Wu, Zhihong Yang, Konstantinos Mavrommatis, Ellen Filvaroff